Table 1.
Reports of thyroid metastases from breast carcinoma.
| Study | Year | No. of patients | Age(years) | Sex | Histology | Interval between Breast cancer and thyroid metastasis (months) | Others metastasis | Treatment | Survival time after diagnosis (months) |
|---|---|---|---|---|---|---|---|---|---|
| Kim et al. (3) | 2005 | 5 | 34–55 | F | Ductal carcinoma | 18–85 | Lung, neck LN | Chemotherapy | 4–26 |
| Owens et al. (10) | 2005 | 1 | 64 | F | NA | 5 | Liver, shoulder | NA | NA |
| Zhou et al. (1) | 2019 | 8 | 43–69 | F | Adenocarcinoma, Ductal carcinoma, Signet ring cell carcinoma, | 6–82 | Chest wall, Lung, Cervical and Mediastinal LN |
Chemotherapy, total thyroidectomy, Right lobectomy |
4–45 |
| Egana et al. (11) | 2012 | 1 | 83 | F | Infiltrating lobular carcinoma | 3 | Live and bone | Left lobectomy | 1 |
| Lacka et al. (6) | 2012 | 1 | 54 | F | Ductal-lobular carcinoma | 14 | Live, lung | Total thyroidectomy |
3 |
| Bourcier et al. (19) | 2018 | 1 | 54 | F | Lobular carcinoma | NA | Cervical LN | Total thyroidectomy and cervical lymph node dissection, Endocrine therapy | NA |
| Pensabene et al. (4) | 2018 | 1 | 64 | F | Infiltrating lobular carcinoma | 6 | Bone | Left lobectomy | 45 |
| Ghias et al. (5) | 2019 | 1 | 67 | F | Ductal carcinoma | NA | Right cerebellopontine angle | Right lobectomy | NA |
| Present study | 2021 | 1 | 54 | F | Ductal carcinoma | 22 | Cervical LN, chest wall | Chemotherapy | NA |
F, female; LN, lymph node; NA, Not available.